Alteration of splicing signals in a genomic/cDNA hybrid VEGF gene to modify the ratio of expressed VEGF isoforms enhances safety of angiogenic gene therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/16039163

Download in:

View as

General Info

PMID
16039163